Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03836521
Other study ID # Pro00047203
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 15, 2016
Est. completion date August 15, 2028

Study information

Verified date February 2019
Source Cedars-Sinai Medical Center
Contact Sung-Han Yoon, M.D.
Phone 3104237426
Email Sunghan.Yoon@cshs.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date August 15, 2028
Est. primary completion date August 15, 2028
Accepts healthy volunteers No
Gender All
Age group 19 Years to 129 Years
Eligibility Inclusion Criteria:

1. Age=18 years.

2. Severe aortic stenosis with bicuspid anatomy.

3. NYHA=2 and/or syncope and/or angina.

4. Patient judged by the Heart Team as indicated for TAVR.

Exclusion Criteria:

1. Age <18 years

2. Asymptomatic patients

3. Pure aortic regurgitation.

Study Design


Intervention

Device:
Transcatheter aortic valve replacement


Locations

Country Name City State
United States Cedars-Sinai Medical Center Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
Cedars-Sinai Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Death Death from any cause 1 month
Primary Death Death from any cause 1 year
Primary Death Death from any cause 2 years
Primary Death Death from any cause 3 years
Primary Death Death from any cause 4 years
Primary Death Death from any cause 5 years
Secondary Death from cardiac cause Death from cardiac cause 1 month
Secondary Death from cardiac cause Death from cardiac cause 1 year
Secondary Death from cardiac cause Death from cardiac cause 2 years
Secondary Death from cardiac cause Death from cardiac cause 3 years
Secondary Death from cardiac cause Death from cardiac cause 4 years
Secondary Death from cardiac cause Death from cardiac cause 5 years
Secondary Stroke disabling and non-disabling stroke 1 month
Secondary Stroke disabling and non-disabling stroke 1 year
Secondary Stroke disabling and non-disabling stroke 2 years
Secondary Stroke disabling and non-disabling stroke 3 years
Secondary Stroke disabling and non-disabling stroke 4 years
Secondary Stroke disabling and non-disabling stroke 5 years
Secondary Repeat hospitalization Number of hospitalizations 1 month
Secondary Repeat hospitalization Number of hospitalizations 1 year
Secondary Repeat hospitalization Number of hospitalizations 2 years
Secondary Repeat hospitalization Number of hospitalizations 3 years
Secondary Repeat hospitalization Number of hospitalizations 4 years
Secondary Repeat hospitalization Number of hospitalizations 5 years
Secondary Bleeding Life-threatening or major bleeding rate 1 month
Secondary Bleeding Life-threatening or major bleeding rate 1 year
Secondary Bleeding Life-threatening or major bleeding rate 2 years
Secondary Bleeding Life-threatening or major bleeding rate 3 years
Secondary Bleeding Life-threatening or major bleeding rate 4 years
Secondary Bleeding Life-threatening or major bleeding rate 5 years
Secondary Vascular complication Major vascular complication 1 month
Secondary Vascular complication Major vascular complication 1 year
Secondary Vascular complication Major vascular complication 2 years
Secondary Vascular complication Major vascular complication 3 years
Secondary Vascular complication Major vascular complication 4 years
Secondary Vascular complication Major vascular complication 5 years
Secondary Acute kidney injury (stage 2 or 3) 1 month
Secondary Acute kidney injury (stage 2 or 3) 1 year
Secondary Acute kidney injury (stage 2 or 3) 2 years
Secondary Acute kidney injury (stage 2 or 3) 3 years
Secondary Acute kidney injury (stage 2 or 3) 4 years
Secondary Acute kidney injury (stage 2 or 3) 5 years
Secondary Prosthetic regurgitation by Doppler echocardiography at discharge
Secondary Prosthetic regurgitation by Doppler echocardiography 1 month
Secondary Prosthetic regurgitation by Doppler echocardiography 1 year
Secondary Prosthetic regurgitation by Doppler echocardiography 2 years
Secondary Prosthetic regurgitation by Doppler echocardiography 3 years
Secondary Prosthetic regurgitation by Doppler echocardiography 4 years
Secondary Prosthetic regurgitation by Doppler echocardiography 5 years
Secondary Mean aortic valve gradient by Doppler echocardiography 1 month
Secondary Mean aortic valve gradient by Doppler echocardiography 1 year
Secondary Mean aortic valve gradient by Doppler echocardiography 2 years
Secondary Mean aortic valve gradient by Doppler echocardiography 3 years
Secondary Mean aortic valve gradient by Doppler echocardiography 4 years
Secondary Mean aortic valve gradient by Doppler echocardiography 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT01390181 - The Effect of Losartan in Bicuspid Aortic Valve Patients N/A
Enrolling by invitation NCT06212050 - Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
Active, not recruiting NCT03635424 - Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study N/A
Recruiting NCT06153407 - Genetic Test Based Risk Prediction of Early Calcific Aortic Valve Disease in Patients With Bicuspid Aortic Valve
Active, not recruiting NCT03474159 - Evaluation of Aortic Stiffness as a Prognostic Indicator of Aortic Dilatation in Patients With Bicuspid Aortic Valve by Multimodal Imaging N/A
Not yet recruiting NCT06375590 - NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International Experience
Recruiting NCT05739253 - Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
Completed NCT01823432 - Genetic Risks for Bicuspid Aortic Valve Disease
Completed NCT02679261 - Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve Phase 3
Completed NCT01920815 - Bicuspid Valve Aortopathy Feasibility Study
Recruiting NCT04817735 - The CASPER Registry N/A
Recruiting NCT02899624 - Whole Exome Sequencing in Bicuspid Aortic Valve Patients N/A
Recruiting NCT05708118 - Progression of Ascending Aorta Diameters in Bicuspid Aortic Valve After Transcatheter or Surgical Replacement.
Recruiting NCT03495050 - BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.
Completed NCT01760668 - Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome N/A
Not yet recruiting NCT05711693 - Measurement of Heart-carotid Pulse Wave Velocity (hcPWV) by Laser Doppler Vibrometry (LDV) N/A
Completed NCT05836363 - Fate at Long-term of Mild to Moderate Bicuspid Aortic Valve Disease Left Untreated at the Time of Supracoronary Ascending Aorta Replacement
Completed NCT02283970 - Investigation of Patients With BAV Requiring Valve and/or Aortic Repair (GISSI Outliers VAR)
Active, not recruiting NCT01026571 - Identification of Genetic Causes of Bicuspid Aortic Valve Disease
Completed NCT00412386 - Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve N/A